PARALAX Life Sciences Investment and Executive Consulting Group of Companies for Innovative Implementation of Medical and Life Science Products and Services.

Slides:



Advertisements
Similar presentations
Setting up a Molecular Lab in a Developing Country
Advertisements

Electric Vehicles Industrial Cluster - NPO IKEM Corp. (Business entity of EVIC) Changing the Government Agenda of EU's poorest countries using the power.
¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Dr. M. Iwasaki 1 Asian Multinational Clinical Trials - Current Status & Future Direction - Dr.Masaru IWASAKI PR Japan Operations Center Aventis Pharma,
Senate Education Committee Briefing Russell Ingram, Executive Director March 23, 2011.
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
EXHIBITORS. JL Shepherd & Associates is a provider of instruments for radiation detection instrumentation. The company was formed in 1967 and it principally.
EMERGING AND RE-EMERGING INFECTIOUS DISEASES: A CONTINUOUS CHALLENGE FOR EUROPE STOA - AVIESAN Workshop June 19th 2012, European Parliament, Bruxelles.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
1 Life Technologies™ Proprietary | AIPLA Winter Meeting Presentation January 2013.
REG set up: first steps… Alison Chisholm 7.40 am – 7:45 am.
Medical Research BADRAG meeting Jan 2013 Dr H Sari-Kouzel.
European Parliament Advanced Therapies Hearing May 11, 2006 Advanced Therapies The proposed EU regulation from the viewpoint of a Pharmaceutical company.
05/09/2015www.ecrin.org1 European Clinical Research Infrastructures Network
Enriching Drug Development through Insightful Trial Design
The Infectious Diseases Institute Kampala, Uganda InfoPoverty World Conference United Nations InfoPoverty World Conference United Nations Robert L. Mallett.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Stakeholders In Clinical Research Government and Regulatory Bodies Professor Phil Warner.
Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
A project implemented by the HTSPE consortium This project is funded by the European Union SECURITY AND CITIZENSHIP.
Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.
INTRODUCTION TO RA.
Presentation for the HBCB Meeting by Irena Bushandrova, Country Manager Bulgaria November 4, 2010.
The French National Agency for Research on Aids and Viral Hepatitis – Clinical Research Legislation: A French Experience Ingrid Callies Legal Counsel in.
Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.
Access to Personalised Medicine for PDAC patients STSM of the application of an EU-index for barriers Denis Horgan (EAPM) & Angela Brand (IPHG) on behalf.
Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.
Consent for Research Study A study using 18 F-Fluoride for prostate cancer patients currently enrolled in Dr. Febbo’s “Genomic Guided Therapy” study A.
Hospital Administration. It is the management of the hospital as a business. The administration is made up of medical and health services managers (sometimes.
Laboratory Results and Operations in WHO Phase 6 Dr. Attaporn Taweetungtragoon CYBELES Phnom Penh, Cambodia October 12-15, 2009.
Training Plan for SAPS Officials by NHLS Ms. Nimee Dhuloo.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
“28,424 cases of Ebola and still counting—what have we learned
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
Overcoming challenges in pediatric oncology product development: Regulatory oversight of multi-national clinical studies Ursula Kern, Advisory Committees.
Health Technology Assessment Methodology, an EUnetHTA View Basics for the Assessment in EU Countries PharmDr. Martin Visnansky, MBA, PhD., MSc. (HTA) HTA.
Technology of healthcare  BY: seemeka Johnson. Technology of healthcare Doctors now know that genetics play a part in possibly passing on diseases from.
The Basque Foundation for Health and Innovation Research Demotek Demonstration Unit of Innovative Technologies in Health An opportunity for.
Regulatory Updates Health Sciences Authority Singapore
A capacity building programme for patient representatives
Translational Research Why should you care about translational research? The public cares. Translation into therapies justifies spending on science.
The Essentia Institute of Rural Health (EIRH) is
LEISHMANIASIS RESEARCH NETWORK (REDELEISH): EXPERIENCE IN LATIN AMERICA 6th World Congress on Leishmaniasis 16th - 20th May 2017 Toledo Spain Joelle Rode1;
Community Participation in Research
The International Cancer Expert Corps (ICEC) mentorship model for sustainable cancer care in Low- and Middle Income Countries (LMIC) and indigenous populations.
Integrating Genetics & Genomics Education into Nursing Workforce
Baltic TRAM: Project Facts Full name: Transnational Research Access in the Macroregion Project period: partners,
Compensation Committee 2017 Goals – Updated
Learning About PET/CT Scans:
A Centre for New Methods in Computational Diagnostics and Personalised Therapy This EU H2020 ‘Teaming for Excellence’ project develops a Business Case.
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Tbilisi Oncodipensary - Tbilisi Cancer Center
National Experimental Therapy Partnership
GMHC Board of Directors November 14, 2016
MONOJO Biotech Services Centre.
What is CICATS? The University of Connecticut, in partnership with regional hospitals, state agencies, and community health care organizations, has.
Implementation: the Case of Egypt
MONOJO Biotech Services Centre.
Joint inspections and cooperation with other institutions in Bulgaria
EuroNHID project Scientific Contents
There is no problem without a solution!
SAMPLE ONLY Dominion Health Center: Your Community Healthcare Home (or another defining message) Dominion Health Center is a community health center.
An Agency Perspective on Plain Language Summaries of Publications
CPSA 4 Corners Initiative 2018
Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Global Forecast to 2026
Presentation transcript:

PARALAX Life Sciences Investment and Executive Consulting Group of Companies for Innovative Implementation of Medical and Life Science Products and Services in Bulgaria

What is PLS? A private equity company; Dedicated to Life Sciences and development of new healthcare strategies; Investments from private funds in Bulgaria, Germany, Austria; € 3 500 000 invested since 2008; 23 successful companies; 200 jobs created.

Selected Portfolio of Companies Other related Life Sciences Ascendent Medical Center ProDuCt/ Milray/ CCDRD/ Milray Moldova – clinical trials and personalized medicine projects SGP Biodynamics – wholesaler of medical devices NM Genomix– transplantation of cells, B2C genetic diagnosis Pharmalex Bulgaria – vigilance of drugs, medical devices and cosmetics Institute for Medical Research – clinical and scientific services NM Consult Simbula – consulting company MilREIT – real estate holding and management company Several start-ups 3 NGO’s in public interest

Why Partners Choose Paralax LS? Existing infrastructure, including a wholesaler of medical devices and 4 companies for clinical trials in its portfolio; Excellent contacts with KOLs and stakeholders in all fields of Life Science in Bulgaria; Employees with relevant expertise in co-operation with competent authorities; A good network and extensive capacity to expand.

Main Credentials Comprehensive regulatory services; Non-disclosure & confidentiality; Long term commitment; Expertise in management of “difficult” and complex medical projects in tough environment; Excellent contacts in key EU countries.

Retail Human Genetics Offering non-invasive prenatal testing – Prenatest®, Cystic fibrosis screening test, FraX, Factor V Leiden, etc.; Oncology – Maintrac®, Treatment Map®, BRCA; Ambry Genetics; Personalization of therapy – EGFR, RAS, BRAF testing; Validation tests for Trovagene and The Genomic Institute of Singapore / non-disclosable due to NDA; Partnering with MammaPrint. *All this activities without an own genetic lab

Wholesale of Diagnostic and Life Science Solutions In Vitro Diagnostics – infectious diseases, oncology, and human genetics; Applied Testing – forensics, food safety, and veterinary medicine; Life Science Solutions – DNA and RNA extraction, PCR kits and reagents, oligonucleotides and genomic services; expression studies Lab Automation – sample disruption, nucleic acid extraction, detection (analysis), quality assessment, liquid handling, and general equipment.

Clinical Trials in Germany, Bulgaria and Moldova Existing since 1994; 10 + inspections from competent authorities – France, Spain, South Africa, Bulgaria; 150+ audits during different trials; Huge expertise in BE trials / 20+ annually/ and phase III trials; Fast and reliable process for permission of clinical trials; CRA rental might be discussed; Fast recruitment of patients in specific areas.

Outpatient Medical Center Profile in endocrinology and female health; Local independent ethics committee, inspected and audited from the Bulgarian Drug Agency; 5-7 Phase III trials p.a.; 10 BE trials p.a. in the dedicated department with 13 beds; Long history of clinical trials; Existing reliable database of patients and healthy volunteers; Doctors with several GCP trainings and record of clinical trials; English speaking coordinator of CT with GCP trainings.

Personalized Medical Solutions Offering complete workflow for personalized therapy in cancer and hepatitis patients to big pharma; Genetic testing is not covered by the National health Insurance Fund; RAS, EGFR, BRAF, PDL1 testing; Patients centricity of the workflow; TAT for the entire testing up to 1 week.

Clinical and Scientific Services Scientific projects - exploratory data analysis, abstract writing, literature search services, statistical and epidemiological reports, research proposals, Integrated Summary of Efficacy (ISE) and Integrated Summary of Safety (ISS), etc.; Validation studies – know-how in oncology and infectious diseases; IMR, along with Joint Genomic Center (JGC), Department of Medicine of the University of Padua (Italy), Hospital for Women‘s Health – “Nadezhda”, and Conofrance/CTI Biotech (France), is a founding partner of Innovation Cluster for Modern Personalization of the Transplantation of Organs, Tissues and Cells.

Additional Information http://paralaxlife.eu/ http://www.ascendent.bg/ http://www.nmgenomix.com/ http://www.simbula.eu/ http://www.ccdrdag.com/ http://www.milray.org/ http://sgpbiodynamics.com/ http://pharmalex.com/ http://www.iqsbulgaria.com/ https://imresearch.co/ http://www.bapemed.org/

THANK YOU! JIVKO IVANOV Managing Director, PARALAX Life Sciences JSC mobile +359 884 572 775 e-mail jivko.ivanov@simbula.eu address 45 Bacho Kiro Str., Sofia, Bulgaria website http://paralaxlife.eu/